The Heat Biologics Inc. (HTBX) shares are trading at higher $2.46 and the avg recommendation for the stock is Moderate Buy. while the current analyst price target stands at $4.00.
To add more color to this target, the company’s high over the last year is $2.58 and the low is $0.19. Over the last 52 weeks, HTBX is down -4.65% while the S&P 500 is up 0.29%. The catalyst for this interesting swing was the company’s recent earnings report.
A Notable Earnings Report
In the last quarter, HTBX reported a profit of $6.03 million. Heat Biologics Inc. also saw revenues increase to $0.9 million. In addition, HTBX has free cash flow of -$5.81 million as of 03-2020. The company’s EBITDA came in at -$5.06 million which compares well with its peers.
HTBX Return on Equity (ROE) is -103.60%, and its Return on Assets is -69.90%. All told, it is clear that, HTBX needs to be on your watchlist.
Find out when HTBX reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. HTBX has a short ratio of 0.09 and outstanding shares of 82.70M.
HTBX has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 95.31 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -0.54. Heat Biologics Inc. HTBX also noted assets of $37.82 million at the end of the last quarter. Investors should also keep an eye on sector updates as HTBX has historically followed its peers on positive news.
All told, Heat Biologics Inc. HTBX has strung together solid data and demonstrated underlying fundamentals. At its current valuation, HTBX represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.
Heat Biologics Inc. HTBX is now commanding a market cap of 166.79M and a float of 75.53M. HTBX is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of HTBX stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in HTBX, either long or short, and we have not been compensated for this article.